Wayne Carter

Company: TVAX Biomedical LLC

Job title: President and CEO

Seminars:

Targeting the Immunosuppressive Tumor Microenvironment through Combining the TVAX Vaccination & Adoptive Cell Therapy Platform with OV 10:00 am

• How the TVAX immunotherapy platform employs multiple modalities, including vaccination and autologous adoptive T cell therapy to target recurrent glioblastoma • How to address challenges in targeting the tumor microenvironment, demonstrated through clinical data from patients with newly diagnosed glioblastoma receiving the TVIBrain-1 • How to overcome tumor microenvironment immunosuppression through the combination of…Read more

day: Day Two

Panel Discussion: Shaping the Future of Cancer Immunotherapy Combinations with Strategic Partnerships & Collaborations to Bring Precise & Effective Treatments to Patients 9:30 am

• How to successfully identify complimentary immuno-oncology platforms such as adoptive cells, Bispecific T cell engagers, oncolytic viruses and beyond to discover and develop novel and life-saving cancer immunotherapy combinations? • How to overcome challenges such as stakeholder management, funding and resource to provide a wide range of cancer patients with improved access to treatment…Read more

day: Day One